Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reliability of patient-reported toxicities during adjuvant chemotherapy.
Cremante M, Pastorino A, Ponzano M, Grassi M, Martelli V, Puccini A, Catalano F, Murianni V, Iaia ML, Puglisi S, Gandini A, Fornarini G, Caprioni F, Andretta V, Pessino A, Comandini D, Sciallero MS, Mammoliti S, Sormani MP, Sobrero A. Cremante M, et al. Among authors: andretta v. Eur J Cancer. 2023 Mar;182:115-121. doi: 10.1016/j.ejca.2023.01.005. Epub 2023 Jan 14. Eur J Cancer. 2023. PMID: 36758476
First-line single-agent cetuximab in patients with advanced colorectal cancer.
Pessino A, Artale S, Sciallero S, Guglielmi A, Fornarini G, Andreotti IC, Mammoliti S, Comandini D, Caprioni F, Bennicelli E, Andretta V, Siena S, Sobrero A. Pessino A, et al. Among authors: andretta v. Ann Oncol. 2008 Apr;19(4):711-6. doi: 10.1093/annonc/mdm516. Epub 2007 Dec 10. Ann Oncol. 2008. PMID: 18073221 Free article. Clinical Trial.
Two doses of NGR-hTNF in combination with capecitabine plus oxaliplatin in colorectal cancer patients failing standard therapies.
Mammoliti S, Andretta V, Bennicelli E, Caprioni F, Comandini D, Fornarini G, Guglielmi A, Pessino A, Sciallero S, Sobrero AF, Mazzola G, Lambiase A, Bordignon C. Mammoliti S, et al. Among authors: andretta v. Ann Oncol. 2011 Apr;22(4):973-978. doi: 10.1093/annonc/mdq436. Epub 2010 Sep 20. Ann Oncol. 2011. PMID: 20855468 Free PMC article. Clinical Trial.
Phase II study of NGR-hTNF, a selective vascular targeting agent, in patients with metastatic colorectal cancer after failure of standard therapy.
Santoro A, Rimassa L, Sobrero AF, Citterio G, Sclafani F, Carnaghi C, Pessino A, Caprioni F, Andretta V, Tronconi MC, Finocchiaro G, Rossoni G, Zanoni A, Miggiano C, Rizzardi GP, Traversari C, Caligaris-Cappio F, Lambiase A, Bordignon C. Santoro A, et al. Among authors: andretta v. Eur J Cancer. 2010 Oct;46(15):2746-52. doi: 10.1016/j.ejca.2010.07.012. Epub 2010 Aug 12. Eur J Cancer. 2010. PMID: 20708923 Clinical Trial.
Defining the Middle Corona.
West MJ, Seaton DB, Wexler DB, Raymond JC, Del Zanna G, Rivera YJ, Kobelski AR, Chen B, DeForest C, Golub L, Caspi A, Gilly CR, Kooi JE, Meyer KA, Alterman BL, Alzate N, Andretta V, Auchère F, Banerjee D, Berghmans D, Chamberlin P, Chitta LP, Downs C, Giordano S, Harra L, Higginson A, Howard RA, Kumar P, Mason E, Mason JP, Morton RJ, Nykyri K, Patel R, Rachmeler L, Reardon KP, Reeves KK, Savage S, Thompson BJ, Van Kooten SJ, Viall NM, Vourlidas A, Zhukov AN. West MJ, et al. Among authors: andretta v. Sol Phys. 2023;298(6):78. doi: 10.1007/s11207-023-02170-1. Epub 2023 Jun 14. Sol Phys. 2023. PMID: 37325237 Free PMC article. Review.
12 results